photo of syringe
New In Our Summer-2009 Update

King Guide Internet Edition
The online interface has been redesigned to simplify multiple drug search results in order to make it easier to view complex compatibility information by method of admixture (Y-Site, Syringe, Admixture). (more...).

Summer-2009

We have added new monographs for these parenteral products: ESOMEPRAZOLE SODIUM, MOXIFLOXACIN HYDROCHLORIDE, and ZICONOTIDE.
               
We have also added new compatibility and stability information to these monographs: AMIODARONE HYDROCHLORIDE,       ATROPINE SULFATE, CEFTRIAXONE SODIUM, MORPHINE SULFATE, MORPHINE HYDROCHLORIDE, OCTREOTIDE ACETATE, OMEPRAZOLE SODIUM, PRALIDOXIME CHLORIDE, and TRAMADOL HYDROCHLORIDE.

Past Updates

Order Form

King Guide - Injectable Drug Compatibility
Setting the standard in injectable drug compatibility information since 1971.

The King Guide to Parenteral Admixtures has provided the most up-to-date, complete and innovative injectable drug compatibility and stability information since 1971. As a 'standard' reference in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs. No other IV drug reference has this much to offer:

The King® Guide to Parenteral Admixures®
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.

Prevent Medication Errors

The single largest cause of medication errors is incomplete information and potentially the most costly are those involving intravenous drug therapy. Immediate access to accurate, up-to-date, authoritative highly specialized compatibility information is therefore essential if such medication errors are to be avoided.

By providing the King Guide on a variety of media practitioners can quickly lookup compatibility and stability information at any time. Simply put, there is a King Guide for every setting, often for less cost than a single improperly prepared admixture which must be discarded.

Are You Missing Vital Information? (more...)
As of October 2008, other references still do not include the following:

Piperacillin and Tazobactam
In 2006, Piperacillin and Tazobactam was reformulated thereby invalidating all previous compatibility studies. The King Guide has reported only studies for the newly formulated product since early 2007.

Ceftriaxone Sodium
In June of 2007, the FDA issued a stern warning that no patient of any age should have Ceftriaxone (Rocephin®) administered within 48 hours of any medication containing calcium. The King Guide has reported this information since September of 2007.

Features (more...)
  • Over 17,000 drug combinations in 12 fluids
  • Includes information on the routes, dosages, temperatures, and containers used to determine compatibility and stability.
  • Includes special sections on stability.
  • Y-Site. Syringe, and other sets/container specific information.
  • Extensive TPN/TNA data are presented in a format with which comparisons can be made for evaluating the compatibility of similar admixtures.
  • Compatibility symbols in the "grid" provide at a glance compatibility information for 12 fluids and are explained with the routes, dosages, and temperatures reported to determine compatibility and stability.
  • A general remarks section discusses procedures for reconstitution stability under various conditions, and precautions to be observed in preparation and administration.
Sample Pages & Quick Links (more...)

The King Guide is also available...